Your browser doesn't support javascript.
loading
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry.
Tong, Liangqin; Wang, Lin; Liao, Shumin; Xiao, Xiaoping; Qu, Jing; Wu, Chunli; Zhu, Yibin; Tai, Wanbo; Huang, Yanhong; Wang, Penghua; Li, Liang; Zhang, Renli; Xiang, Ye; Cheng, Gong.
Afiliação
  • Tong L; Tsinghua-Peking Joint Center for Life Sciences, Beijing Frontier Research Center for Biological Structure and Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
  • Wang L; Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
  • Liao S; Tsinghua-Peking Joint Center for Life Sciences, Beijing Frontier Research Center for Biological Structure and Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
  • Xiao X; Department of Otolaryngology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Qu J; Department of Thoracic Surgery, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Wu C; Tsinghua-Peking Joint Center for Life Sciences, Beijing Frontier Research Center for Biological Structure and Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
  • Zhu Y; Institute of Pathogenic Organisms, Shenzhen Center for Disease Control and Preventiongrid.464443.5, Shenzhen, Guangdong, China.
  • Tai W; Institute of Pathogenic Organisms, Shenzhen Center for Disease Control and Preventiongrid.464443.5, Shenzhen, Guangdong, China.
  • Huang Y; Tsinghua-Peking Joint Center for Life Sciences, Beijing Frontier Research Center for Biological Structure and Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua Universitygrid.12527.33, Beijing, China.
  • Wang P; Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
  • Li L; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Zhang R; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
  • Xiang Y; Department of Immunology, School of Medicine, the University of Connecticut Health Center, Farmington, Connecticut, USA.
  • Cheng G; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
mBio ; 13(4): e0148522, 2022 08 30.
Article em En | MEDLINE | ID: mdl-35862773
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article